JEE Advanced 2025 result releasing today: Direct link, steps to download scorecard on jeeadv.ac.in
The Indian Institute of Technology (IIT) Kanpur is set to announce the
JEE Advanced 2025 result
today, 2 June, at 10 am. Students who took the engineering entrance exam can check their scores on the official website, jeeadv.ac.in.
When was the exam held?
JEE Advanced 2025 was held on 18 May in two shifts: Paper 1 and Paper 2. According to students and experts, the maths section was tougher than usual, while the physics and chemistry papers were more straightforward.
How to check JEE Advanced 2025 result?
Here are the steps to check your result:
Go to the official website, jeeadv.ac.in
Click on the link for 'JEE Advanced Result 2025'
Enter your roll number and date of birth
Your result will be shown on the screen
Download and print a copy for future use
The final answer key has also been released along with the result so students can cross-check their answers.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Sbocciano i fiori ma anche le offerte!
ho. Mobile
Acquista Ora
Undo
How is the ranking done?
The rank is based on total marks scored in maths, physics and chemistry. To be eligible, students need to clear both the subject-wise and overall cut-off.
Why is this result important?
Last year, the results were announced on 9 June. The earlier release this year has brought some relief to thousands of students waiting anxiously.
Live Events
For any future updates, students should keep checking the official website.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Rare brain eating amoeba Naegleria fowleri kills woman: How a tiny amoeba in tap water can kill you and how to stay safe
A woman in Texas died after contracting a deadly brain infection from a microscopic amoeba in tap water used for a nasal rinse, U.S. health officials have confirmed. The 71-year-old was reportedly staying at a local campground and had used water from her RV's tap in a nasal irrigation device. Just four days later, she developed severe neurological symptoms and died within eight days of falling ill. The U.S. Centers for Disease Control and Prevention (CDC) has identified the infection as primary amebic meningoencephalitis (PAM), caused by Naegleria fowleri — a rare but nearly always fatal amoeba. 'This case reinforces the potential for serious health risks associated with improper use of nasal irrigation devices, as well as the importance of maintaining RV water quality and ensuring that municipal water systems adhere to regulatory standards,' the CDC stated. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Experience next-level CPAP comfort with Resmed AirSense 11 ResMed Enquire Now Undo What is Naegleria fowleri? Naegleria fowleri is a single-celled organism that lives in warm freshwater bodies such as lakes, rivers, and hot springs. It can also survive in poorly maintained swimming pools and untreated tap water. It is referred to as a "brain-eating amoeba" because, once it enters through the nose, it travels along the olfactory nerve into the brain, where it destroys brain tissue. Despite its terrifying name, the amoeba is extremely rare. Between 1962 and 2023, only 164 cases were recorded in the U.S., with just four known survivors. Live Events Tammy Lundstrom, Chief Medical Officer and infectious disease expert at Trinity Health, told Fox News Digital, 'The risk of brain-eating amoeba is very low. Fewer than 10 people in the U.S. every year get infected — but unfortunately, most cases are fatal. There are only a handful of survivors of known cases.' How the woman got infected The CDC's Morbidity and Mortality Weekly Report detailed that the woman had used a nasal irrigation device multiple times over four days. It was filled with unboiled tap water from the RV's internal plumbing. After symptoms such as fever, headache and altered mental status emerged, she was hospitalised and treated for a suspected PAM infection. However, her condition rapidly worsened. She suffered seizures and died eight days after the symptoms began. Testing of her cerebrospinal fluid confirmed the presence of Naegleria fowleri. Although the amoeba itself was not detected in the RV water supply, investigators found the system had not been adequately disinfected. Symptoms to watch for Early symptoms of PAM often appear within five days of exposure, though onset can range from one to 12 days. These include: Headache Fever Nausea Vomiting As the infection advances, it can cause: Confusion Stiff neck Seizures Hallucinations Coma 'Early symptoms should prompt a medical evaluation, as they are also signs of bacterial meningitis,' said Lundstrom. The disease progresses swiftly. On average, death occurs five days after symptoms begin, but it can happen in as little as one day or as long as 18. How to protect yourself The CDC advises that only sterile, distilled or previously boiled and cooled water should be used for nasal rinsing. Improperly treated water, especially from RVs or municipal systems lacking adequate disinfection, can pose a risk. When swimming, experts recommend keeping your head above water or using a nose clip. 'Infection occurs when water harbouring the amoeba goes up a person's nose, usually during swimming,' Lundstrom explained. 'It is not known why some people get infected and others, even swimming companions, do not.' Drinking contaminated water is not a risk factor, as the infection only occurs via nasal exposure. It also does not spread between people. Because the amoeba thrives in warm temperatures — typically over 30°C — and can survive in sediment, swimmers are advised not to disturb the bottom of lakes or rivers. How it spreads and survives Naegleria fowleri has three life stages: cyst, trophozoite (the active stage), and flagellate. The active form can infect humans but under less favourable conditions, it reverts to a cyst and clings to surfaces in plumbing or pools. It grows best at temperatures up to 46°C and can survive briefly even in hotter conditions. Most infections occur in southern U.S. states, though cases are being reported further north — possibly linked to climate change. To limit the spread, many southern utilities perform annual chlorine burns at the start of summer to flush out biofilms where the amoeba might hide. Can it be treated? Treatment options are limited due to the rapid progression and severity of PAM. Doctors typically use antifungal and antibiotic drugs, such as rifampin and azithromycin, alongside miltefosine, a newer antifungal that has shown some promise in lab tests. But Lundstrom cautioned, 'The effect of all of these drugs on actual infected people is unknown due to the high fatality rate.' Prompt diagnosis remains difficult because early symptoms resemble other, more common infections. The warmest months are when Naegleria fowleri is most active, especially in southern regions. Splash pads, lakes, and even backyard kiddie pools can become risky if water is left untreated or stagnant. Though infections are rare, families are urged to take simple precautions. Use sterile water for nasal care. Be cautious in warm freshwater environments. And remember, the amoeba doesn't pose a risk in saltwater or from drinking. 'Millions of people enjoy swimming every summer, but only a few become infected,' said Lundstrom. 'Awareness and prevention are your best tools.'
Time of India
6 hours ago
- Time of India
Cabinet nod to Rs 1,113cr biotechnology devpt scheme
1 2 3 Bhubaneswar: The state cabinet, under the chairmanship of chief minister Mohan Charan Majhi, on Friday approved a comprehensive five-year biotechnology development scheme with an outlay of Rs 1,113.50 crore. The programme will be implemented from 2025-26 to 2029-30. The 'Development of Biotechnology' initiative, comprising 17 sub-schemes, aims to transform Odisha into a knowledge-driven bio-economy by leveraging the state's rich biodiversity and existing research infrastructure. "This scheme will create a robust ecosystem for innovation, incubation and investment in the biotechnology sector," a govt statement said. The programme aligns with the state's Industrial Policy Resolution (IPR) 2022, which identifies biotechnology as a thrust sector. The scheme's primary objectives include promoting higher education and research infrastructure, developing a supportive ecosystem for innovation and industry, aligning academic excellence with industry requirements and facilitating product development and commercialisation. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 임플란트 최대 할인 지원해드려요 임플란터 더 알아보기 Undo It will also promote utilising biotechnology innovations for socio-economic development. The new scheme aims to bridge the gap between academia and industry while fostering collaboration across sectors including agriculture, medicine and environmental sciences. The initiative complements the recently announced Odisha Biotechnology Policy, 2024, offering incentives for advanced infrastructure development and positioning the state as a biotechnology hub. The cabinet also gave its nod to modalities of the Mukhyamantri Sahari Bikash Yojana (MSBY), with a massive outlay of Rs 6,000 crore over five years. The scheme, aligned with the state's "Viksit Odisha@2036 vision", aims to revolutionise urban infrastructure and boost revenue generation across cities. For the initial year (2025-26), the state has allocated Rs 1,100 crore in the last budget. The scheme, scheduled to run from 2025-26 to 2029-30, will focus on four key areas — urban infrastructure development, wage employment, water body development and animal welfare. Under the infrastructure component, the scheme will develop various facilities, including kalyan mandaps and multi-purpose halls, market complexes and vending zones, roads, drains, and parking facilities and EV charging stations, among others. The cabinet also gave its nod to exempt land premium of Rs 2.60 crore for lease of a piece of land to Narcotics Control Bureau for construction of its building. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !
Time of India
6 hours ago
- Time of India
Maha's anti-venom pioneer targeted by predatory journal
Mumbai: The world of medical research is battling its own version of cyber frauds: predatory or 'pseudo' journals, deceptive publications that claim to be scholarly but rarely follow ethical publishing practices and seek hefty payment from authors. On Friday, Dr Himmatrao Bawaskar (75), a Mahad-based physician who won a Padma Shri in 2022 and is known for his rural Maharashtra medical practice and research, wrote in 'The Lancet' about his two-year struggle with a predatory journal that swiftly published his work, then started demanding 1,000 pounds and issued threats when he objected. "I received threatening emails stating they would take serious action and damage my reputation in India," he said. Mahad-based Dr Himmatrao Bawaskar, whose pioneering work in anti-venom for scorpions and snakes has been published in numerous peer-reviewed medical journals, was so "devastated" by his struggle with a predatory journal that he developed "anxiety, insomnia and palpitation". Within six months, the 75-year-old doctor lost 8 kgs and needed psychiatric help. In recent months, various medical associations across the world have voiced concern about the growing number of predatory journals. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Tausende schwärmen von diesem Nagelpilz-Gerät – wir haben es überprüft Med-Aktuell Undo The International Committee of Medical Journal Editors in Feb estimated there are over 15,000 such journals. While medical research paves the way for new treatments, these journals are undermining its credibility. Dr Bawaskar's ordeal began when he submitted his self-funded diabetes research to high-impact journals. After many rejections, a case report journal approached him. "In my submission to this journal, I stated I work without funding and would not be able to pay fees," he said. Yet the journal sent him a proof in a couple of days. "I was shocked—how could the peer review and publication process be completed so quickly? I again appealed, stating my inability to pay. The journal ignored my requests and proceeded to publish the article, then sent me an invoice with exorbitant fee," he added. The journal then sent threats and said they were giving him "a 40% discount." "But during a call with my son who is a cardiologist in the US, my wife mentioned my stress to him," said the doctor. His son identified the predatory nature of the journal and blocked their communications. While the doctor hasn't paid the journal, this experience has prompted him to work out a checklist. He said, "Since this episode, I have not attempted to publish again. Instead, I find fulfilment in seeing my patients recover and walk again—living testaments to my diagnosis and management; these are my true publications." Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !
